abstract: Abnormal development of invasive trophoblasts has been implicated in the pathogenesis of human pregnancy diseases such as pre-eclampsia. However, critical signalling pathways controlling formation and differentiation of these cells have been poorly elucidated. Here, we provide evidence that the canonical Notch pathway, operating through Notch-dependent activation of its key regulatory transcription factor RBPJk, controls proliferation and differentiation in villous explant cultures and primary trophoblasts of early pregnancy. Immunofluorescence of first trimester placental tissue revealed expression of RBPJk and its co-activators, the MAML proteins, in nuclei of proliferative cell column trophoblasts (CCT) and differentiated, extravillous trophoblasts (EVTs). However, RBPJk expression, transcript levels of the Notch target gene HES1 and activity of a Notch/RBPJk-dependent luciferase reporter decreased during in vitro differentiation of primary cytotrophoblasts on fibronectin. Silencing of RBPJk using silencing RNAs (siRNAs) increased proliferation of CCTs in floating villous explant cultures analysed by outgrowth and BrdU labelling. Similarly, down-regulation of the transcription factor enhanced BrdU incorporation in isolated primary cultures. However, motility of these cells was not affected. In addition, gene silencing of RBPJk increased cyclin D1 expression in the two trophoblast model systems as well as markers of the differentiated, EVT, i.e. integrin a1, ADAM12 and T-cell factor 4. In summary, the data suggest that Notchdependent RBPJk activity could be required for balanced rates of trophoblast proliferation and differentiation in human placental anchoring villi preventing exaggerated trophoblast overgrowth as well as premature formation of EVTs.
Introduction
Invasion of extravillous trophoblasts (EVTs) into maternal uterine tissue is crucial for human placental development. During early stages of pregnancy placental anchoring villi attach to the maternal decidua giving rise to different invasive trophoblast subtypes, i.e. interstitial cytotrophoblasts (iCTBs) and endovascular cytotrophoblasts (eCTBs) migrating into the uterine stroma and its arterial vessels, respectively (Pijnenborg et al., 2006) . After implantation trophoblasts plug the arterial vessels, likely to prevent premature onset of blood flow and oxidative stress in the developing placenta (Burton et al., 2010) . However, between 10th and 18th week of pregnancy extensive spiral artery remodelling occurs enabling subsequent haemotrophic nutrition of the fetus. The process is thought to be initiated by uterine natural killer (uNK) cells and involves both iCTBs and eCTBs resulting in disruption of the muscular arterial wall, vessel elastolysis and replacement of maternal endothelial cells by trophoblasts (Harris, 2011; Robson et al., 2012) . As a consequence, contractility is lowered, and diameter of spiral arteries increases, thereby ensuring continuous, low pressure blood flow to the placenta (Pijnenborg et al., 1983; Burton et al., 2009) . In complicated pregnancies, such as preeclampsia or intrauterine growth restriction (IUGR), incomplete vessel remodelling has been observed likely provoking oxidative stress through hypoxia-re-oxygenation injuries, abnormal secretion and shedding of placental products and subsequent occurrence of clinical symptoms at later stages of gestation (Pijnenborg et al., 1991; Burton et al., 2009; Redman et al., 2012) . Moreover, incomplete plugging of vessels and precocious blood flow to the placenta might cause miscarriage (Hustin et al., 1990) . Hence, poor placentation at early stages of pregnancy is generally considered as the underlying mechanism causing gestational diseases. However, multiple mechanisms are thought to be involved such as adverse immunological acceptance of the fetus after implantation involving unfavourable interactions between invasive trophoblasts and uNK cells expressing polymorphic human leucocyte antigen (HLA)-C2 and Killer immunoglobulin-like receptor, respectively, or possibly failures in the secretion of uterine products supporting placental growth (Hiby et al., 2004; Burton et al., 2007) .
In addition, considerable literature has been published showing that invasive trophoblasts in pre-eclampsia also display abnormal EVT marker expression suggesting that failures in differentiation contribute to the pathogenesis of the particular pregnancy disorder. For example, preeclamptic eCTBs in placental tissues lack expression of critical vascular adhesion molecules such as distinct integrin and cadherins . Similarly, isolated CTBs from patients differentiating in vitro failed to up-regulate critical genes involved in EVT function, such as HLA-G and matrix metalloproteinase (MMP)-9, or were shown to express elevated levels of a negative inhibitor of trophoblast invasion, semaphorin 3B (Lim et al., 1997; Zhou et al., 2013) . Despite these facts the molecular mechanisms and key regulatory pathways controlling physiological as well as abnormal differentiation of EVT remain poorly elucidated.
Recent investigations suggested that signalling pathways controlling embryonic development and tissue homeostasis in adults could also be critically involved in trophoblast formation and differentiation. In particular, Notch signalling, which was shown to control stem cell niches, cell fate decisions and cancerogenesis, also regulates crucial steps of mouse placental development such as branching morphogenesis and vascularization (Gasperowicz and Otto, 2008; Kopan and Ilagan, 2009; Wang et al., 2009) . In general, the family of mammalian Notch receptors consists of four members (Notch1-4) which are activated upon interaction with different types of membrane-bound ligands, the Serrate-like ligands (Jagged1 and 2) and the Delta-like ligands (Dll1, 3 and 4; Fortini, 2009) . Induction of signalling involves two sequential cleavage steps through proteases of the a disintegrin and metalloproteinase (ADAM) family and g-secretase producing the Notch-extracellular truncation fragment and its derivative, the Notch intracellular domain (NICD), respectively (Kopan and Ilagan, 2009 ). Subsequently, the NICD translocates to the nucleus and binds to the key regulatory factor of canonical Notch signalling, recombination signal binding protein for immunoglobulin kappa J region (RBPJk), thereby converting the latter into a transcriptional activator. Interaction of NICD with RBPJk triggers recruitment of additional co-activators such as the Mastermind-like (MAML) family of proteins (MAML1-3) promoting expression of Notch target genes involved in proliferation, differentiation and cell motility (McElhinny et al., 2008) . The effects of Notch are highly variable depending on the particular tissue context and the degree of activation (Mazzone et al., 2010; Perdigoto and Bardin, 2013) . Accordingly, Notch could either act as a tumour suppressor or oncogene in different organs (Rangarajan et al., 2001; van Es et al., 2005) .
Regarding human pregnancy disorders, changes in Notch signalling components have been detected in tissues from patients with preeclampsia or IUGR (De Falco et al., 2007; Sahin et al., 2009) . However, the role of the particular pathway in human placental development and trophoblast differentiation is poorly defined. Recent evidence from our laboratory suggested complex expression patterns of Notch receptors and ligands in different trophoblast subtypes of early human placentae . Moreover, chemical inhibition of g-secretase increased trophoblast proliferation, cell motility as well as differentiation of primary CTBs into EVTs suggesting that canonical Notch signalling could play a critical role in human placental development . However, chemical blockage of g-secretase might also provoke side effects since the enzyme is involved in the generation of several intracellular domains (ICDs) with putative transcriptional activity in trophoblasts such as ICDs of CD44, N-cadherin or ERBB4 (Kopan and Ilagan, 2004) . Hence, to more precisely delineate the function of canonical Notch signalling in trophoblasts, we here performed siRNAmediated gene silencing of its key regulatory transcription factor RBPJk and studied the effects on trophoblast function and differentiation.
Materials and Methods

Tissue collection
First trimester human placentae (6th -12th week of gestational age, n ¼ 105) were obtained from elective, surgical terminations of pregnancies. Use of tissues was approved by the local ethical committee and required informed consent of patients.
Isolation and cell culture of primary first trimester human cytotrophoblasts Primary CTBs of pooled first trimester placentae (6th-12th week of gestational age, n ¼ 82) were isolated according to a modified protocol of Tarrade et al. (2001) as recently mentioned Meinhardt et al., 2014) . Briefly, placentas were washed in ice-cold phosphate-buffered saline and kept overnight in Dulbecco's modified Eagle's medium (DMEM)/Ham's F-12 medium (Life Technologies), supplemented with 0.05 mg/ml gentamicin (Invitrogen) and 2.5 mg/ml fungizone (Invitrogen). Villous tips were scraped off with a scalpel blade and digested two times in 0.125% trypsin (Invitrogen) and 12.5 mg/ml DNase I (Sigma-Aldrich) in 10% HBSS-Mg/Ca-free medium (Sigma-Aldrich) for 30 min at 378C without agitation. Subsequently, cells were pooled, filtered through a 100 mm cell strainer (Greiner Bio-One GmbH) and the cell suspension was separated by Percoll (Pharmacia) density gradient (10-70%) centrifugation (1175g, 24 min, 48C). Isolated cells (between 30 and 50% Percoll layer) were incubated in erythrocyte-lysis buffer (155 mM NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA, pH 7.3) and then seeded onto uncoated wells (40 min, 378C) to separate contaminating fibroblasts. Non-adherent cells were collected and cultivated on fibronectin-coated (20 mg/ml, Millipore) wells at a density of 1.5 × 10 5 cells/cm 2 in DMEM/Ham's F-12 medium, supplemented with 10% fetal calf serum (FCS), 0.05 mg/ml gentamicin and 2.5 mg/ml fungizone. Purity of CTBs (95 -99%) was determined by immunofluorescence in chamber slides using antibodies against vimentin and cytokeratin 7 detecting mesenchymal cells and trophoblasts, respectively, as mentioned Meinhardt et al., 2014) . A representative picture is depicted (Supplementary data, Fig. S1 ). Moreover, cells preparations (n ¼ 4) were analysed by flow cytometry using HLA-G1 and EGF receptor 1 antibodies detecting EVTs (52% + 9 SD) and proliferative CTBs 36% + 12 SD, respectively, as recently mentioned Meinhardt et al., 2014) . Upon cultivation on fibronectin for 48 h EGF receptor 1-positive trophoblasts decreased to 7% + 6 SD, whereas numbers of HLA-G1-positive cells increased (86% + 9 SD) suggesting differentiation of proliferative CTBs into EVTs as shown Meinhardt et al., 2014) .
First trimester placental explant cultures
Villous explants of first trimester placentae (6th-9th week of gestation, n ¼ 16) were dissected under the microscope as mentioned . To evaluate trophoblast outgrowth/motility placental villi were seeded onto collagen I (BD Biosciences, mixed with 10× DMEM and 7.5% sodium bicarbonate) in DMEM/Ham's F-12 medium to allow anchorage. After an additional 5 h, transfection of silencing RNAs (siRNAs) (50 nM, RNAiMAX, Invitrogen) was performed as described above. Forty-eight hours later the area of outgrowth was digitally photographed (Olympus IX71, ColorView III digital camera, Cell^D software; Olympus) and the distance was measured using Illustrator CS5 (Adobe). For each experiment, seven explants per condition were used.
Cultivation of SGHPL-5 cells
SGHPL-5 cells were cultivated in a 1:1 mixture of DMEM/Ham's F-12 (Gibco BRL Life Technologies) supplemented with 0.05 mg/ml gentamicin (Gibco BRL Life Technologies) and 10% FCS (Biochrom AG, Berlin, Germany). Cells were shown to express EVT markers such as cytokeratin 7 and human leucocyte antigen-G (Choy et al., 2000) .
siRNA-mediated gene silencing in primary isolated cytotrophoblasts and placental explant cultures
Thirty minutes after isolation primary, isolated CTBs were transfected by lipofection using RNAiMAX solution (Invitrogen) according to manufacturer's instructions and seeded onto fibronectin-coated wells. Smartpool siRNAs targeting RBPJk (Dharmacon, L-007772-00-0005) and non-targeting control (ntc) siRNAs (D-001810-10-20) were used at a final concentration of 50 nM. The same protocol was used for villous explant cultures, but transfection was performed after anchorage on collagen I (see first trimester placental explant cultures).
Western blot analysis
Cells were lysed in SLAB buffer (30 mM Tris -Cl, 1% SDS, 5% glycerol, 2.5% b-mercaptoethanol), followed by boiling for 10 min. Proteins were separated by SDS -PAGE, blotted onto methanol-activated polyvinylidene difluoride membranes (GE Healthcare) and incubated over night at 48C using antibodies against GAPDH (2118, Cell Signalling, 1:2000), RBPJk (5442, Cell Signalling, 1:500), Maml2 (6988, Cell Signalling, 1:500), Maml3 (PA5-13678, Thermo Scientific, 1:500), ITGA1 (mab 1973, Millipore, 1:1000), TCF-4 (05-511, Upstate, 1:1000), ADAM12 (14139-1-AP, Proteintech Group, 1:500), Cyclin D1 (sc-20044, Santa Cruz, 1:500), caspase-3 (Cell Signalling, 1:1000) or cleaved (ASP175) caspase 3, (5A1E, Cell signalling, 1:1000). Subsequently, membranes were incubated with HRP-linked antimouse or anti-rabbit IgG secondary antibodies (1:25 000; GE Healthcare) for 1 h at room temperature. Blots were developed with ECL Prime Western blotting detection reagent (GE Healthcare) and signals were visualized using MultiImage III FC Light Cabinet and Alpha View 3.1.1.0 software (Alpha Innotech). ImageJ software was used for signal quantification.
RNA extraction and quantitative real-time PCR
Primary CTBs were lysed in 300 ml TriFast (PeqLab) and processed according to manufacturer's instructions. RNA amount and purity were tested using a NanoDrop spectrophotometer (ND-1000, Peqlab). cDNA synthesis, quantitative real-time PCR (qRT-PCR) and calculations were performed as previously described (Saleh et al., 2011) . Taq Man Gene Expression Assay Mix for RBPJk (Hs00794653_m1), cyclin D1 (CCND1; Hs00277039_m1) and TATA-binding protein (TBP, TaqMan endogenous control) were used. For RNA extraction from collagen I-anchored villous explants, tissues were covered with PeqGold TriFast (50 ml, Peqlab) for 5 s and the villous part of the tissues was mechanically removed from the outgrowth. After pooling RNA of residual cell columns and EVTs was isolated as described above.
Immunofluorescence of placental tissues
Serial sections of paraffin-embedded human first trimester placentae or placental explant cultures (7th-12th week of gestational age) were prepared as previously described . For antigen retrieval, a KOS MicrowaveStation (Milestone) and retrieval solution (pH 6, Dako) were used, followed by blocking with 0.05% fish skin gelatin (Sigma-Aldrich). Primary antibodies utilized were cytokeratin 7 (Dako, Clone OV-TL 12/ 30, 1:100), cytokeratin wide spectrum (GeneTex, GTX29377, 1:100), Maml1 (Sigma, HPA037687, 1:50), Maml2 (Sigma, HPA035223, 1:100), Maml3 (Sigma, HPA037717, 1:100), Ki67 (Dako, M7240, 1:100), p57 (Santa Cruz, sc-10401, 1:100), HLA-G1 (MEM/G1, Novus Biologicals, 1:100); BrdU (Dako, Clone Bu20a, 1:100) and incubated in blocking solution over night at 48C. For RBPJk (Santa Cruz, sc-28713) stainings, cryo-sections were prepared and treated as recently mentioned (Bauer et al., 2004) . Subsequently, sections were incubated with goat anti-mouse or anti-rabbit IgG conjugated to Alexa Fluor 488 or Alexa Fluor 568 (2 mg/ml; Life Technologies) for 1 h at room temperature, counterstained with DAPI (1 mg/ml; Roche) and mounted in Fluoromount-G (Southern Biotechnology Associates). Images were acquired on a fluorescence microscope (Olympus BX50, CC12 digital camera, Cell^P software; Olympus).
Luciferase reporter analyses in primary cytotrophoblasts
After isolation CTBs were transfected with Amaxa Basic Nucleofector Kit for primary mammalian epithelial cells (VPI-1005, Lonza) using Nucleofector program W-001. For each transfection, 1.5 × 10 6 cells were resuspended in 100 ml nucleofection buffer containing 3 mg mut-RBPJk (plasmid PJH25A) or wt-RBPJk (plasmid PJH23A) luciferase reporter plasmids (Hsieh et al., 1996) and 0.6 mg CMV-bGal. Transfections were performed in the absence or presence of siRNAs (RBPJk or ntc, 400 nM) and CTBs were seeded onto fibronectin for in vitro differentiation. Analyses of luciferase activity and normalization to constitutive b-galactosidase activity were performed as previously described (Sonderegger et al., 2010) .
Migration assay
Motility assays through uncoated (SGHPL-5 cells) and fibronectin-coated (primary CTBs) transwells were performed as recently mentioned. Briefly, 24 h after siRNA (RBPJk/ntc) transfection, 2 × 10 4 primary cells were seeded onto fibronectin (0.5 mg/ml)-coated transwells (Millipore) and incubated for an additional 24 h in the absence or presence of 10 mM of the g-secretase inhibitor 10_MN-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT). Subsequently, inserts were fixed with ice-cold methanol and non-invaded cells were removed using a cotton swab. Cells which have migrated to the underside of filters were stained with cytokeratin 7 antibodies and counterstained with DAPI. Finally, inserts were embedded in Fluoromount-G and visualized by fluorescence microscopy. Five non-overlapping pictures of each membrane representing 50% of the overall surface were taken (40-fold magnification) and digitally analysed using ImageJ software.
Proliferation assay
Proliferation of primary CTBs was assessed by using BrdU Labeling and Detection Kit II (Roche Diagnostics). Cells were isolated, transfected with siRNAs against RBPJk or ntc and cultured as described above. After 22 h BrdU (10 mM) was added for 2 h before cells were fixed and stained with antibodies against Cytokeratin wide spectrum (GeneTex, GTX29377, 1:100) and BrdU (Dako, clone Bu20a, 1:100). Cells were counterstained with DAPI. Placental floating explants were cultivated for 24 h in DMEM/ Ham's F-12 medium containing 0.05 mg/ml gentamicin and siRNAs against RBPJk or ntc. Subsequently, BrdU (10 mM) was added for an additional 6 h and organ cultures were embedded in paraffin, sectioned and analysed by immunofluorescence as described above. To analyse the proliferation rate of ntc and RBPJk siRNA-treated SGHPL-5 cells, 4 × 10 4 cells were seeded in 24 wells (triplicates), labelled with BrdU for 2 h and, such as primary CTBs, analysed by immunofluorescence and counting of BrdU-positive cells.
Statistical analysis
Statistical analysis was performed with Student's unpaired t-test using SPSS 18 (SPSS Inc.). Gaussian distribution and equality of variances were examined with Kolmogorov-Smirnov test and Levene test, respectively. For multiple comparisons analysis of variance and appropriate post-hoc testing were performed. A P-value of ,0.05 was considered statistically significant. Microarray data retrieved from the Gene Expression Omnibus (GEO) database (GDS3523) were statistically analysed with GeneSpring (Agilent Technologies) using an unpaired t-test with Benjamini -Hochberg correction. A robust multi-array average was utilized as summarization algorithm.
Results
RBPJk and MAML co-activators are expressed in human first trimester placenta and primary CTBs
Immunofluorescence of first trimester placental tissues suggested expression of RBPJk and its co-activators, MAML1 and 3, in Ki67-positive, proliferative cell column trophoblasts (CCTs) as well as in differentiated, p57KIP2-and HLA-G1-expressing EVTs (Fig. 1A) . In contrast, MAML2 was absent in proximal CCTs and increased during EVT formation. Western blot analyses of primary CTBs differentiating in vitro on fibronectin confirmed the expression pattern obtained in the immunofluorescence analyses (Fig. 1B) . Whereas MAML3 did not change during differentiation, MAML2 increased, concomitant with the up-regulation of the EVT markers integrin a1 (ITGA1) and T-cell factor 4 (TCF-4) as previously shown (Damsky et al., 1992; Pollheimer et al., 2006) . Although RBPJk was readily identifiable in EVTs on tissue sections, its expression decreased during CTB differentiation. Two different commercially available antibodies failed to detect MAML1 in western blot analyses, however, analyses of published gene chip data (Bilban et al., 2009) suggested equal transcript levels of MAML1 in five and six different CTB and EVT mRNA pools, respectively (see GEO profiles GDS3523 at NCBI). Quantification of western blot analyses revealed downregulation of RBPJk and induction of MAML2 at 72 h of CTB differentiation (Fig. 1C) . MAML3 did not significantly change compared with protein levels at 24 h of cultivation (arbitrarily set at 100%).
Canonical notch activity and HES1 mRNA decrease during CTB differentiation
To investigate the canonical Notch activity during in vitro differentiation, isolated CTBs were transfected with a canonical Notch reporter harbouring four wt-RBPJk binding sites and seeded onto fibronectin-coated dishes. Analyses of luciferase activity revealed down-regulation of canonical Notch activity at 48 and 72 h of cultivation ( Fig. 2A) . In accordance with diminished reporter activity and RBPJk expression, previously published microarray analyses (Bilban et al., 2009) revealed that transcript levels of one of the prime target genes of canonical Notch signalling, HES1, were lower in differentiated EVTs compared with isolated CTBs (Fig. 2B) . 
siRNA-mediated gene silencing of RBPJk in primary CTBs and villous explant cultures
To analyse RBPJk function during CTB differentiation, the transcription factor was silenced in primary cells and villous explant cultures using specific siRNAs (Fig. 3) . Western blot analyses and quantification of protein levels revealed down-regulation of RBPJk to 21% + 9 SEM in siRNAtreated CTBs (Fig. 3A) . Co-transfection of wt-RBPJk or mut-RBPJk luciferase reporter plasmids in ntc or RBPJk siRNA-treated primary CTBs indicated loss of canonical Notch activity upon silencing of the factor (Fig. 3B) . Similarly, immunofluorescence suggested efficient down-regulation of RBPJk in first trimester villous explant cultures after 24 h of siRNA treatment (Fig. 3C) . Seeding of siRNA-transfected explants on collagen I allowed for subsequent mechanical removal of villous tissues and isolation of RNA from residual anchoring cell columns and EVTs. Quantification of mRNA expression in these cells by real-time PCR revealed downregulation of RBPJk transcript levels to 34% + 8 SEM (Fig. 3D) . Moreover, RBPJk was also silenced in trophoblastic SGHPL-5 cells and quantified by western blotting (Supplementary data, Fig. S2 ).
siRNA-mediated gene silencing of RBPJk increases trophoblast outgrowth from villous explant cultures
Down-regulation of RBPJk by siRNA-mediated gene silencing enhanced trophoblast outgrowth from placental villi anchored to collagen I (Fig. 4A) . Quantification of outgrowth distance revealed an increase to 138% + 13 SEM which could be indicative for elevated trophoblast migration and/or proliferation. Interestingly, primary CTBs did not display increased motility through fibronectin-coated transwells after 48 h of siRNA treatment (Fig. 4B) suggesting that loss of RBPJk predominantly affects trophoblast proliferation. However, the g-secretase inhibitor DAPT increased migration of both ntc and RBPJk siRNAtreated primary cells (Fig. 4B) . Differently to CTBs, siRNA-mediated gene silencing of RBPJk elevated migration of trophoblastic SGHPL-5 cells (Supplementary data, Fig. S3 ) indicating variations between different trophoblast cell models.
siRNA-mediated gene silencing of RBPJk elevates trophoblast proliferation
Floating villous explant cultures treated with ntc or RBPJk siRNAs for 24 h were subsequently incubated with BrdU. Immunofluorescence of paraffin-embedded tissue sections revealed elevated numbers of BrdUpositive CCTs, particularly in the proximal region of the cell column (Fig. 5A ). Quantification by counting positive nuclei indicated that the percentage of BrdU-labelled CCTs significantly increased upon RBPJk knock-down (Fig. 5B) . Similarly, incorporation of BrdU into isolated, primary CTBs was elevated upon siRNA-mediated down-regulation of RBPJk (Fig. 5B) . Accordingly, gene silencing of RBPJk increased cyclin D1 mRNA in cell columns of collagen-I-anchored villous explant cultures ( Fig. 5C ) and cyclin D1 protein expression in primary CTBs (Fig. 5D) , respectively. However, silencing of the factor did not affect proliferation of SGHPL-5 cells, measured by BrdU labelling (Supplementary data, Fig. S4 ).
siRNA-mediated gene silencing of RBPJk does not affect apoptosis
To determine whether increased proliferation upon RBPJk gene silencing could be due to suppression of apoptosis, cleaved caspase-3 expression was analysed in primary CTBs (Fig. 6 ). Western blotting (Fig. 6A) and quantification of signals (Fig. 6B ) revealed that activated, 18 kDa caspase-3 did not significantly change between ntc and RBPJk siRNAtreated cultures suggesting that apoptosis was unaffected by the RBPJk knock-down.
siRNA-mediated gene silencing of RBPJk increases markers of the differentiated EVT
Furthermore, western blot analyses demonstrated elevated expression of the EVT markers ADAM12L, ITGA1 and TCF-4 in primary CTBs after 72 h of RBPJk gene silencing, whereas no differences could be observed at 24 h (Fig. 7A) . Quantification of membranes revealed that compared with ntc (100%) ADAM12, ITGA1 and TCF-4 increased to 140% + 16 SEM, 155% + 24 SEM and 170% + 54 SEM, respectively, in RBPJk siRNA-treated CTBs at 72 h of differentiation (Fig. 7B) . 
Discussion
Besides Wnt, EGF or TGFb signalling, the Notch pathway has been shown to play crucial roles in stem self-renewal, cell fate decisions and differentiation (Watt et al., 2008; Kageyama et al., 2009; Wang et al., 2009; Ogaki et al., 2013) . Notch function highly depends on the cellular context and on its integration with other developmental signalling cascades (Mazzone et al., 2010; Perdigoto and Bardin, 2013) . Accordingly, Notch may act as an oncogene or tumour suppressor in different cells and organs (Rangarajan et al., 2001; van Es et al., 2005) . With respect to placental development, mouse knock-out studies provided evidence for a role of Notch in vascular morphogenesis. Homozygous mutation of receptors (Notch1, Notch2, Notch4), ligands (Dll4) and Notch target genes (Hey1, Hey2) resulted in defects in labyrinth formation and/or chorioallantoic branching (Gasperowicz and Otto, 2008) . Moreover, in RBPJk mutant mice chorioallantoic fusion is blocked and the number of spongiotrophoblasts is reduced, suggesting that the canonical Notch pathway could be important for proliferation and/or suppression of apoptosis of this cell type (Oka et al., 1995; Krebs et al., 2004) . Moreover, Notch2 has been implicated in motility of murine glycogen and trophoblast giant cells since a conditional knock-out of the gene in their progenitors affected endovascular invasion and placental perfusion (Hunkapiller et al., 2011) . Recent studies conducted in our laboratory also suggested that Notch signalling could be critically involved in controlling CCT proliferation and invasive differentiation. Immunofluorescence of first trimester placental tissues revealed expression of Notch1, 2 and 3 in trophoblast cell columns, whereas EVTs only expressed Notch2, suggesting that activity of the Notch pathway could be largely confined to proliferative trophoblast progenitors . To further investigate this assumption, we here tested expression of the Notch key regulatory transcription factor RBPJk, its transcriptional co-activators, the MAML proteins, as well as the activity of a canonical Notch reporter during in vitro CTB differentiation on fibronectin. Whereas MAML1 and MAML3 did not change during EVT formation, RBPJk mRNA and protein expression decreased. Concomitantly, RBPJk-dependent reporter activity diminished during differentiation and transcripts encoding the canonical Notch target gene HES1 were expressed at lower levels in EVTs compared with CTBs. Decreased HES1 mRNA expression in EVTs compared with CTBs was also detectable in gene chip analyses of others (Apps et al., 2011) .
Hence, combined evidence suggested that canonical Notch activity decreased along the invasive trophoblast differentiation pathway. Interestingly, MAML2 increased during differentiation potentially suggesting a special role for MAML2-RBPJk complexes in EVTs. On the other hand, all MAML proteins also fulfil functions independently of Notch signalling such as activation of p53-or MEFC2-dependent transcription (McElhinny et al., 2008) . Moreover, MAMLs were also shown to bind to b-catenin and thereby co-activate T-cell factors (TCFs), the key regulatory transcription factors of canonical Wnt signalling (Alves-Guerra et al., 2007) . Therefore, increased expression of MAML2 in EVTs could be of particular interest since TCF-4 protein levels and TCF/b-catenindependent transcription are induced during invasive trophoblast differentiation (Pollheimer et al., 2006; Knö fler and Pollheimer, 2013; Meinhardt et al., 2014) .
Inhibition of canonical Notch activity by chemically blocking g-secretase was recently shown to increase outgrowth in first trimester villous explant cultures on collagen I and motility of SGHPL-5 cells through uncoated and fibronectin-coated transwells . Furthermore, the g-secretase inhibitors L-685,458 and DAPT also increased migration of freshly isolated as well as differentiated CTBs suggesting that canonical Notch activity impaired trophoblast motility . Herein, gene silencing of RBPJk increased trophoblast outgrowth in explant cultures and SGHPL-5 cell motility, but did not affect migration of primary CTBs, although motility of the latter could be increased with DAPT. Hence, the combined data suggest that DAPT and L-685,458 might provoke side effects in EVTs independently of their role as inhibitors of canonical Notch activity. Indeed, inhibition of g-secretase affects different signalling processes since the enzyme was shown to cleave numerous substrates at the intracellular region of the membrane once their extracellular domains have been removed by proteases such as tumour necrosis factors-a-converting enzyme (TACE) or MMP-7 (Kopan and Ilagan, 2004) . Both TACE and MMP-7 are expressed on trophoblasts (Vettraino et al., 1996; Ma et al., 2011) . Hence, ICDs of ERBB4, CD44, N-cadherin, Jagged, lowdensity lipoprotein receptor-related protein (LRP) and others (Kopan and Ilagan, 2004) could be generated in invasive trophoblasts, co-activate transcription and thereby negatively regulate trophoblast migration. On the other hand, RBPJk also fulfils functions independently of Notch signalling by activating or repressing gene transcription (Johnson and Macdonald, 2011) . Hence, it cannot be ruled out that a putative, antagonistic effect of RBPJk on trophoblast motility, as was observed upon chemical inhibition of g-secretase, might have been compensated by non-canonical effects of the transcription factor. Furthermore, comparison of the present data with our aforementioned study ) also suggests differences between SGHPL-5 cells and the primary trophoblast models systems. Whereas neither addition of DAPT nor siRNA-mediated silencing of RBPJk affected SGHPL-5 cell proliferation, both treatments increased BrdU labelling in primary CTBs as well as in vCTBs and CCTs of floating villous explant cultures. Discordant results between primary trophoblasts and SGHPL-5 cells could be explained by differences in Notch receptor expression, the latter lacking Notch4. Alternatively, high proliferation rates of SGHPL-5 cells, as a consequence of SV40 large-T transfection to generate the cell line (Choy et al., 2000) , could not be further stimulated upon inhibition of canonical Notch signalling.
Active Notch signalling is often associated with maintenance of stem cells at a low proliferative capacity in different organs thereby preventing overgrowth of tissues and precocious differentiation (Koch et al., 2013) . For example, conditional knock-out of RBPJk in neuronal stem cells of mice was shown to deplete the progenitor cell pool and to induce premature differentiation (Imayoshi et al., 2010) . In contrast, overexpression of HES genes or a dominant-active Notch1 inhibited neuronal differentiation but promoted a glial cell fate (Ishibashi et al., 1994; Gaiano et al., 2000; Koch et al., 2013) . Interestingly, the homozygous mutation of RBPJk in the brain led to differentiation of neuronal stem cells into proliferative, transit-amplifying cells and to a transient increase in neurogenesis before the stem cell pool was completely depleted (Imayoshi et al., 2010) . Similarly, blocking Notch activity in neuronal stem cells of zebrafish strongly induced proliferation, increased numbers of neurons and subsequent loss of stem cells (Chapouton et al., 2010) . Previous results and the data presented here suggest that the canonical Notch pathway might operate in a similar fashion during human trophoblast development and placental organogenesis. Notch receptors (Notch1, Notch2, Notch3) were found to be predominantly expressed in proliferative CCTs and, with the exception of Notch2, decreased during EVT formation. Accordingly, canonical Notch activity and expression of one of the major target genes, HES1, also diminished during the invasive differentiation process. In intestinal stem cells HES1 was shown to inhibit cell cycle exit and differentiation by repressing the cyclindependent kinase inhibitors p21KIP1 and p57KIP2 (Riccio et al., 2008) . In this context, it is noteworthy that, concomitant with the downregulation of HES1, both kinase inhibitors are induced during EVT formation as shown here and by others (Genbacev et al., 2000) . DAPT treatment and siRNA-mediated silencing of RBPJk increased proliferation of vCTBs and CCTs as well as cyclin D1 expression in primary CTBs and villous explant cultures which might reflect conversion of trophoblast progenitors into transit-amplifying cells. Furthermore, chemical inhibition of g-secretase as well as silencing of RBPJk increased differentiation of CTBs into EVTs. Down-regulation of RBPJk elevated cell-specific markers of invasive trophoblasts such as ITGA1, Wnt-dependent TCF-4 and ADAM-12. The latter has recently been identified as an EVT-restricted gene in the human placenta (Aghababaei et al., 2013; Biadasiewicz et al., 2014) . Therefore, inhibition of canonical Notch activity might also induce precocious differentiation of trophoblast progenitors into EVTs.
In summary, the data suggest that canonical Notch activity mediated through RBPJk controls balanced proliferation rates of CCTs and their differentiation into invasive trophoblasts. Notch signalling could be required to maintain trophoblast progenitors and to inhibit trophoblast overgrowth and premature differentiation along the invasive trophoblast lineage. For maintenance of a RBPJk-dependent stem cell niche in the proximal cell column diverse interactions between Notch1, 2, 3 and the ligands Jagged1, Jagged2, DLL1, DLL4, all expressed in CCTs , could play a role. Hence, further studies are needed to dissect the individual functions of Notch receptors and ligands in column formation and differentiation.
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